BR three-lens brief
Evidence-based stock research on BR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $206.50 — 38% above current (8 analysts). · Trading at 11% of its 52-week range — deep in the lower band.
- Trading at 11% of its 52-week range — deep in the lower band.
- Analyst mean target $206.50 — 38% above current (8 analysts).
BR closed at $149.66 (+1.59%) as of 2026-07-10. Market cap: $17.31B. P/E (trailing) 16.0. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $206.50 — 38% above current (8 analysts).. Concerns: trading at 11% of its 52-week range — deep in the lower band.. Last quarter: Revenue $1.95B, net income $276.30M, free cash flow $1.19B.
Why three lenses on BR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BR brief"></iframe>